Related Experiment Video
Updated: Jul 25, 2025
09:58
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
13.8K
A new gene-scoring method for uncovering novel glaucoma-related genes using non-negative matrix factorization based
Xiaoqin Huang1, Akhilesh K Bajpai2, Jian Sun3
1Department of Ophthalmology, University of Tennessee Health Science Center, Memphis, TN, United States.
Frontiers in Genetics
|June 28, 2023
Summary
This study introduces a novel gene scoring method combined with Non-negative Matrix Factorization (NMF) for identifying glaucoma biomarkers. This approach significantly enhances the detection of crucial glaucoma genes from transcriptome data.
Area of Science:
- Genomics
- Ophthalmology
- Bioinformatics
Background:
- Early diagnosis and treatment of glaucoma remain significant challenges.
- Gene expression data holds potential for discovering glaucoma biomarkers.
- Non-negative Matrix Factorization (NMF) is a powerful tool for transcriptome analysis but underutilized in glaucoma research.
Purpose of the Study:
- To apply NMF and a novel gene scoring method to identify glaucoma biomarkers from RNA-seq data.
- To compare the efficacy of NMF with traditional differentially expressed gene (DEG) analysis for glaucoma gene enrichment.
- To validate the developed pipeline on an independent dataset.
Main Methods:
- Non-negative Matrix Factorization (NMF) was applied to RNA-seq data from BXD mouse strains.
- A novel gene scoring method was developed to rank genes based on their relevance.
- Glaucoma-reference genes were identified from multiple resources for enrichment analysis.
- Comparison with classical DEG analysis and validation on an independent dataset were performed.
Main Results:
- The NMF-based method significantly improved the enrichment detection of glaucoma-related genes compared to DEG analysis.
- The combined NMF and gene scoring approach demonstrated high potential for identifying glaucoma marker genes.
- The pipeline was successfully validated on an independent RNA-seq dataset, confirming its robustness.
Conclusions:
- The integration of NMF with a novel gene scoring method offers a promising strategy for glaucoma biomarker discovery.
- This approach can provide new insights for early diagnosis, monitoring, and treatment of glaucoma.
- Further application of this pipeline could advance glaucoma research and clinical practice.
Related Concept Videos
02:24Ribosome Profiling
3.6K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.6K
03:21RNA-seq
10.1K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
10.1K